deoxycytidine has been researched along with Duodenal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abi-Jaoudeh, N; Avital, I; Beane, JD; Beresnev, T; Griffin, KF; Levy, EB; Pandalai, P; Rudloff, U; Shutack, Y; Webb, CC; Wood, B | 1 |
| Ishihara, T; Miyakawa, K; Sakai, Y; Sugiyama, H; Tomizawa, M; Tsuyuguchi, T; Yokosuka, O | 1 |
1 trial(s) available for deoxycytidine and Duodenal Diseases
| Article | Year |
|---|---|
Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advance
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Catheterization; Deoxycytidine; Duodenal Diseases; Duodenum; Female; Gastrointestinal Hemorrhage; Gemcitabine; Humans; Ischemia; Male; Maximum Tolerated Dose; Middle Aged; Pancreas; Pancreatic Neoplasms; Perfusion; Splenic Artery; Treatment Outcome | 2015 |
1 other study(ies) available for deoxycytidine and Duodenal Diseases
| Article | Year |
|---|---|
[Case of intrahepatic cholangiocarcinoma drained through a fistula of the duodenal bulb].
Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Deoxycytidine; Duodenal Diseases; Duodenal Neoplasms; Female; Gemcitabine; Humans; Intestinal Fistula; Liver Neoplasms; Neoplasm Invasiveness | 2010 |